K. Stoschitzky et al., STEREOSELECTIVE VASCULAR EFFECTS OF THE (R)-ENANTIOMERS AND (S)-ENANTIOMERS OF PROPRANOLOL AND ATENOLOL, Journal of cardiovascular pharmacology, 25(2), 1995, pp. 268-272
All beta-adrenergic antagonists have an asymmetric carbon atom, and mo
st commercially available beta-blockers consist of (R)- and (S)-enanti
omers in a fixed 1:1-ratio. The drugs are believed to be contraindicat
ed when peripheral vascular disease exists, presumably due to unoppose
d alpha-adrenergic vasoconstriction. However, little is known about di
rect vascular effects of beta-blockers or of stereoselective effects o
n peripheral arteries. Therefore, we investigated the effects on forea
rm blood flow (FBF) of brachial artery infusions of the (R)- and (S)en
antiomers of propranolol and atenolol (2, 10, and 50 mu g/min each) an
d their inhibitory effects on isoprenaline (Iso)-induced vasodilatatio
n by forearm venous occlusion plethysmography in 12 healthy subjects.
Only (R)propranolol caused an increase in FBF(+21%, p < 0.05), whereas
(S)-propranolol and (R)- and (S)-atenolol had no direct effect on per
ipheral arteries. Vasodilatation induced by Iso was abolished by (S)-p
ropranolol and reduced by (R)-propranolol (-56%, p < 0.05) and (S)aten
olol (-68%, p < 0.05), whereas (R)-atenolol had no effect. Our results
indicate that the optically pure (R)- and (S)-enantiomers of proprano
lol and atenolol do not exert direct vasoconstrictive effects. Further
more, our results confirm that predominantly (S)-enantiomers have beta
-adrenoceptor blocking effects, but they also show that neither the no
n-beta-blocking (R)-enantiomer of propranolol nor the (S)-enantiomer o
f the beta(1)-selective agent atenolol is completely devoid of blockin
g effects on vascular beta(2)-adrenoceptors.